Buy CLSI M S 23ED PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING from SAI Global. CLSI document MS24 (ISBN Replaces MS23 Wayne, PA: Clinical and Laboratory Standards Institute; CLSI () Performance Standards for Antimicrobial Susceptibility Testing; CLSI Approved Standard MS Clinical and Laboratory Standards Institute.
|Published (Last):||11 January 2005|
|PDF File Size:||19.31 Mb|
|ePub File Size:||16.40 Mb|
|Price:||Free* [*Free Regsitration Required]|
Clinical and Laboratory Standards Institute, Wayne.
In spite of the availability of commercial kits for 203 detection in the market, the Clinical and Laboratory Standards Institute CLSI recommends the use of phenotypic methods, such as the disk diffusion method with oxacillin or with cefoxitin, as well as a serial dilution method with oxacillin.
There is a version specifically designed for pharmacists to enhance the implementation of M information tailored to their organization. Laboratory identification of MRSA is crucial and essential both for initiation of appropriate antimicrobial therapies and for effective infection control strategies that are designed to limit the spread of MRSA.
Furthermore, the borderline value of zone inhibition diameters for cefoxitin might be considered as a risk, and they may give false-susceptible result.
The aim of the study described in this paper was to comparatively evaluate the traditional susceptibility testing for MRSA with PCR as the gold standard assay. Advances in MicrobiologyVol. In contrast, the disk diffusion methods with oxacillin and cefoxitin showed lower sensitivity Nevertheless, some studies have shown that results obtained with such phenotypic methods are controversial.
The Clinical and Laboratory Standards Institute CLSI is a not-for-profit membership organization that brings together the varied perspectives and expertise of the worldwide laboratory community for the advancement of a common cause: Work more efficiently by providing the latest recommendations for detecting emerging resistance in an easy-to-use format.
Updated Version of CLSI’s Best-Selling Standard-MSis Now Available – IFCC
Advancing excellence in laboratory medicine for better healthcare worldwide. Methicillin-resistant Staphylococcus aureus MRSA is a multi-drug resistant pathogen, which is responsible for increasing cases of serious diseases, including life-threatening diseases and nosocomial and community-acquired infections.
Scientific Research An Academic Publisher. Environmental Standards and Trade Volume. For additional information, visit the CLSI website at www.
MS23 includes a dosage regimen for imipenem for Pseudomonas aeruginosa and new information for detection of inducible clindamycin resistance using the D-zone test or broth microdilution for Streptococcus pneumoniae.
Expanded recommendations for testing fluoroquinolones and salmonella, and elimination breakpoints for beta-lactamase, other than oxacillin cefoxitinpenicillin, and ceftaroline for staphylococci are included.